Skip to content
lifestyle.pspl.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Biodexa Pharmaceuticals PLC
Approval from Health Canada to expand Serenta Registrational Phase 3 trial in FAP and Update on Serenta Progress
June 29, 2026
Postponement and Re-scheduling of Annual General Meeting
June 17, 2026
Biodexa issues letter to Shareholders
May 21, 2026
Biodexa Licenses Phase 1 Ready Drug Candidate from Otsuka for Rare Stomach Cancer
February 19, 2026
←
Previous Page
1
2